About
Mr. Novik founded PROLOR Biotech, Inc., a biopharmaceutical company developing long-acting therapeutic proteins, in 2005, and served as its President through its acquisition by OPKO Health (NYSE: OPK) in 2103, a $560 million transaction. Mr. Novik is a co-founder or GlassesOff, and previously served as Chief Operating Officer and Head of Strategic Planning of THCG, a technology and life sciences investment company. THCG was a portfolio company of Greenwich Street Partners, one of the largest U.S. private equity funds. THCG's own portfolio included several life sciences and medical devices companies. Prior to his position at THCG, Mr. Novik served as Chief Operating Officer and Chairman of Strategy Committee of RogersCasey, an investment advisory company serving Fortune 500 companies such as DuPont, Kodak, General Electric and others.
Position in the VCSift Database
- • 398 investors hold the Chairman role in VCSift. Shai Novik is one of them.
- • 610 investors are based in Israel.
Data sourced from 410,343 investor profiles. Updated July 2026.
Contact Information
Find more investors like Shai
Search Investors